Surveillance Cultures and Infection in 230 Pacemaker and Defibrillator Generator Changes in Pediatric and Adult Congenital Patients

2021 ◽  
Vol 12 (3) ◽  
pp. 331-336
Author(s):  
Gregory Webster ◽  
Lauren C. Balmert ◽  
Ami B. Patel ◽  
Larry K. Kociolek ◽  
Melanie Gevitz ◽  
...  

Background: Postoperative infections can occur during surgical replacement of pulse generators for pacemakers and implantable cardioverter-defibrillators. The incidence of infection is poorly documented in children and patients with adult congenital heart disease. The utility of surveillance cultures obtained from device pocket swabs is unknown in this group. Methods: We reviewed surgical replacements of cardiovascular implantable pulse generators from 2010 to 2017. Two cohorts were defined. In a surveillance cohort (123 patients), aerobic and anaerobic culture swabs of the device pocket were obtained at the time of generator change. In a nonsurveillance cohort (107 patients), generator change occurred without obtaining cultures. Results: During 230 generator changes (mean patient age 19 years; 77% with structural congenital heart disease), two clinical infections occurred at the surgical site (0.9% incidence). Neither infection occurred in the surveillance cohort. Cultures were positive in 12 (9.8%) of 123 patients in the surveillance cohort, but 11 of 12 were likely contaminants and none were subsequently associated with clinical disease. There was no association between clinical infection or positive surveillance cultures and the location of pulse generator, the presence of other concurrent surgeries, or a history of prior pocket infection. Conclusions: Clinical infection was rare after pulse generator change in children and young adults. No cases required reintervention on the pocket. Surveillance cultures did not improve clinical care. These data extend current recommendations that surveillance cultures are not required during generator change to the pediatric and young adult population.

ESC CardioMed ◽  
2018 ◽  
pp. 2244-2247
Author(s):  
Sunil Kapur ◽  
Saurabh Kumar

Advances in surgery and clinical care have resulted in a progressive increase in life expectancy of patients with congenital heart disease (CHD). Cardiac arrhythmias are a common and onerous complication in CHD, of which atrial fibrillation (AF) is rapidly increasing in prevalence. AF frequents coexists with intra-atrial reentrant tachycardias. AF onset and prevalence may vary as a function of the congenital lesion as well as the operative repair. AF progression to a persistent or permanent form may be rapid. Cardioembolic risks in this population are higher compared to those without CHD. Common cardioembolic risk predictors lack validation in this population. Rhythm control with antiarrhythmic drugs can be challenging due to low efficacy and toxicity. Rate control is critical as AF with rapid ventricular rates may be poorly tolerated in patients with complex CHD and may be associated with an increased risk of sudden cardiac death. There is limited evidence for the role of percutaneous catheter ablation for AF. Concurrent atrial arrhythmia surgery should be considered in patients with a prior history of AF scheduled to undergo open cardiac surgery primarily to address an underlying cardiac lesion. Much further work is needed to expand our understanding of the mechanism of AF in CHD and improve efficacy of catheter ablation in this population.


Sign in / Sign up

Export Citation Format

Share Document